PubRank

Sue Ashley

Author PubWeight™ 47.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 2007 3.39
2 Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 2002 3.01
3 Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood 2011 2.14
4 Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res 2006 1.71
5 Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients--audit and treatment algorithm. Acupunct Med 2005 1.54
6 A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004 1.49
7 Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy. J Thorac Oncol 2010 1.46
8 Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease. J Pediatr Hematol Oncol 2004 1.45
9 Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 2010 1.43
10 90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial? Eur J Cancer 2008 1.39
11 Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol 2013 1.23
12 Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors. Eur J Cancer 2011 1.12
13 Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007 1.09
14 Chemotherapy in clear cell sarcoma. Med Oncol 2011 0.98
15 Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study. J Clin Oncol 2009 0.98
16 Feasibility of the use of the Active Breathing Co ordinator (ABC) in patients receiving radical radiotherapy for non-small cell lung cancer (NSCLC). Radiother Oncol 2009 0.97
17 Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis. Childs Nerv Syst 2009 0.95
18 Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor. Neuro Oncol 2010 0.94
19 Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom. Clin Cancer Res 2006 0.94
20 Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival. J Thorac Oncol 2007 0.93
21 Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int 2008 0.93
22 Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer. Eur J Cancer 2011 0.91
23 The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer. Lung Cancer 2006 0.90
24 The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy. Eur J Cancer 2011 0.89
25 Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma. Sarcoma 2010 0.88
26 Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clin Cancer Res 2006 0.86
27 Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. Eur J Cancer 2010 0.85
28 Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET. Pediatr Blood Cancer 2008 0.84
29 Sternal/para-sternal resection for parasternal local recurrence in breast cancer. Breast 2010 0.83
30 Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol 2011 0.83
31 HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients. Breast 2008 0.83
32 Management of anemia in patients receiving chemotherapy. J Clin Oncol 2002 0.83
33 Inflammatory breast cancer--The Royal Marsden Hospital experience: a review of 155 patients treated from 1990 to 2007. Cancer 2010 0.80
34 Time trends in the outcome of elderly patients with breast cancer. Breast J 2008 0.80
35 BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial. Cancer Lett 2006 0.80
36 Fractionated stereotactic radiotherapy in the treatment of vestibular schwannoma (acoustic neuroma): predicting the risk of hydrocephalus. Int J Radiat Oncol Biol Phys 2010 0.80
37 Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease. Radiother Oncol 2005 0.79
38 Assessment of gemcitabine, cisplatin and methylprednisolone (GEM-P) combination treatment for non-Hodgkin T cell lymphoma. Med Oncol 2012 0.79
39 Long-term efficacy of fractionated radiotherapy for benign meningiomas. Radiother Oncol 2013 0.78
40 Factors determining outcome after third line chemotherapy for metastatic breast cancer. Breast 2007 0.78
41 Cone beam CT verification for active breathing control (ABC)-gated radiotherapy for lung cancer. Acta Oncol 2013 0.77
42 Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer. Breast Cancer Res Treat 2007 0.77
43 A study to look at the effects of a hydrolat spray on hot flushes in women being treated for breast cancer. Complement Ther Clin Pract 2008 0.76
44 Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer. Lung Cancer 2007 0.75
45 Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers. Fam Cancer 2014 0.75
46 Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible? Lung Cancer 2004 0.75
47 Thirty-day mortality in critical care outreach patients with cancer: an investigative study of predictive factors related to outreach referral episodes. Resuscitation 2010 0.75
48 Comparison of forward planning with automated inverse planning for three-dimensional conformal radiotherapy of non-small cell lung cancer without IMRT. Radiother Oncol 2006 0.75